|Articles|September 7, 2022
- Applied Clinical Trials-09-01-2022
- Volume 31
- Issue 9
Applied Clinical Trials September 2022 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials September 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 3 years ago
The Powerful Impact of Caregivers on Clinical Trialsabout 3 years ago
Clinical Research Needs Greater Participant Diversityabout 3 years ago
The Eradication of False Signals in Monitoringabout 3 years ago
‘Record’ Gains in Bringing Research Closer to the Patientabout 3 years ago
Contemplating a Pressing Drug Development Paradoxabout 3 years ago
Evaluating the Use of Backup Solutions for ePRO Systemsabout 3 years ago
Filling the Gaps in Clinical Trial Education, Literacyabout 3 years ago
CRAACO, Moving Trials Closer to Patientsabout 3 years ago
Getting Up to Speed on EU’s New Trial Application Systemover 3 years ago
Top Priority for Califf is Combating Health MisinformationNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
4
ACT Brief: Designing Feasible Protocols and Breakthroughs in Obesity and Metabolic Research
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
